Portación faríngea de Mycoplasma pneumoniae en niños chilenos

S., Camilo Palma; S., Marcia Salinas; G., Pamela Rojas

doi:10.4067/s0716-10182005000300005

Cited by 9 publications

(5 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Other studies also reported low rates of carriage in healthy persons. Palma et al (82) found that only 4/185 asymptomatic children in Chile were PCR positive. Reasons for different carriage rates among published studies are not readily apparent, other than they could be related to the prevalence of the organisms in the local community at a given time.…”

Section: Infection and Carriage In The Upper Respiratory Tractmentioning

confidence: 99%

Mycoplasma pneumoniae from the Respiratory Tract and Beyond

et al. 2017

View full text Add to dashboard Cite

is an important cause of respiratory tract infections in children as well as adults that can range in severity from mild to life-threatening. Over the past several years there has been much new information published concerning infections caused by this organism. New molecular-based tests for detection are now commercially available in the United States, and advances in molecular typing systems have enhanced understanding of the epidemiology of infections. More strains have had their entire genome sequences published, providing additional insights into pathogenic mechanisms. Clinically significant acquired macrolide resistance has emerged worldwide and is now complicating treatment. susceptibility testing methods have been standardized, and several new drugs that may be effective against this organism are undergoing development. This review focuses on the many new developments that have occurred over the past several years that enhance our understanding of this microbe, which is among the smallest bacterial pathogens but one of great clinical importance.

show abstract

Section: Infection and Carriage In The Upper Respiratory Tractmentioning

confidence: 99%

Mycoplasma pneumoniae from the Respiratory Tract and Beyond

et al. 2017

View full text Add to dashboard Cite

show abstract

“…Únicos estudios latinoamericanos, efectuados en Argentina y Panamá, revelan una prevalencia de infección respiratoria baja por M. pneumoniae de 15 y 7% respectivamente 6,7 . En Chile no se conoce la prevalencia de esta infección; sin embargo, una investigación efectuada en consultorios de atención primaria de la Región Metropolitana (comunas de Maipú y La Florida) buscó la presencia de M. pneumoniae en secreción faríngea utilizando reacción de polimerasa en cadena (RPC), en niños asintomáticos y encontró 2% de portación faríngea 8 . Hasta hace un tiempo se estimaba que las edades más afectadas eran los escolares y los adultos jóvenes; sin embargo, en los últimos años, se ha visto que las infecciones por este microorganismo se producen más precozmente, ya antes de los tres años de vida 9 .…”

Section: Discussionunclassified

Manifestaciones muco-cutáneas de la infección por Mycoplasma pneumoniae: Presentación de cuatro casos

B¹,

R²,

C³

et al. 2009

Rev. chil. infectol.

View full text Add to dashboard Cite

Mucocutaneous findings of the Mycoplasma pneumoniae infection: Presentation of four cases. The mucocutaneous manifestations of Mycoplasma pneumoniae infection appear in approximately 20 % of all the infections produced by this microorganism. Maculopapular rash, vesicular or urticarial exanthemas, are frequent manifestations that can constitute Erythema multiforme or more rarely, Stevens-Johnson syndrome or epidermal toxic necrolisis. We describe the clinical evolution, diagnosis and treatment of four children with mucous and cutaneous manifestations associated to infection by Mycoplasma pneumoniae and a review of the medical literature.

show abstract

“…Para la detección de M. pneumoniae existen múltiples métodos 13,18,37,38 . La serología es el método empleado con mayor frecuencia 13 , siendo el estándar dorado para el diagnóstico la seroconversión entre muestras de suero en fase aguda y de convalecencia 3 .…”

Section: Discussionunclassified

“…Se estima que, del número total de NAC causadas por M. pneumoniae, sólo 2 a 4% requerirá hospitalización 12 . Un estudio en nuestro medio 13 , investigó la presencia de M. pneumoniae en secreción faríngea de 185 niños asintomáticos, detectando 2% de portación faríngea. No existen datos locales que revelen cuál es la prevalencia de esta infección en niños.…”

Section: Introducción Eunclassified

Características clínicas de la enfermedad respiratoria causada por Mycoplasma pneumoniae en niños hospitalizados

Vega-Briceño

et al. 2009

Rev. chil. infectol.

View full text Add to dashboard Cite

Introduction: Studies on Mycoplasma pneumoniae infection are scarce in Chile. Objective: To describe clinical characteristics associated with M. pneumoniae in children requiring hospitalization. Material and Methods: All children with a respiratory infection requiring hospitalizations between 2000-2005, whom had a M. pneumoniae specific IgM ≥ 1:32, were analyzed.Results: Fifty children meeting study criteria were identified with an average length of hospitalization of 4 days (range: 1-10); mean age was 5.4 years (46% were younger than 5 years). Common clinical features were cough (92%), fever (82%), malaise (74%) and respiratory distress (72%). At admission 40/45 children had hypoxemia. Chest-X ray showed interstitial pattern (69.3%), consolidation (51%) and hyperinsuflation (28.5%). Six patients had pleural effusion. Eighty four percent of patients had a favorable clinical outcome; eight children required admission to the PICU all of whom recovered. Conclusion: Respiratory infections associated with M. pneumoniae in our series of children had a highly variable and non-specific clinical spectrum. Chest-X rays showed different pattern in concordance with previous publications.

show abstract

Portación faríngea de Mycoplasma pneumoniae en niños chilenos

Cited by 9 publications

References 17 publications

Mycoplasma pneumoniae from the Respiratory Tract and Beyond

Mycoplasma pneumoniae from the Respiratory Tract and Beyond

Manifestaciones muco-cutáneas de la infección por Mycoplasma pneumoniae: Presentación de cuatro casos

Características clínicas de la enfermedad respiratoria causada por Mycoplasma pneumoniae en niños hospitalizados

Contact Info

Product

Resources

About